4//SEC Filing
Mickle Travis C 4
Accession 0001437749-21-020865
CIK 0001434647other
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 4:51 PM ET
Size
20.2 KB
Accession
0001437749-21-020865
Insider Transaction Report
Form 4
KEMPHARM, INCKMPH
Mickle Travis C
DirectorPresident & CEO10% Owner
Transactions
- Other
Common Stock
2021-08-24−96,153→ 23,354 total - Other
Common Stock
2021-08-24+96,153→ 96,153 total(indirect: By LLC) - Other
Common Stock
2021-08-24−3,125→ 29,271 total - Other
Common Stock
2021-08-24+1,341→ 32,396 total - Other
Common Stock
2021-08-24−6,287→ 0 total - Award
Stock Option (right to buy)
2021-08-20+263,743→ 263,743 totalExercise: $9.06Exp: 2031-08-19→ Common Stock (263,743 underlying) - Other
Common Stock
2021-08-24−7,701→ 0 total(indirect: By Trust) - Other
Common Stock
2021-08-24+7,701→ 31,055 total - Other
Common Stock
2021-08-24−1,341→ 0 total(indirect: By Trust)
Holdings
- 9,824(indirect: By Trust)
Common Stock
- 15,242(indirect: By Trust)
Common Stock
- 1,034(indirect: By LLC)
Common Stock
Footnotes (6)
- [F1]The Reporting Person is the sole manager member of Mickle Holdings, LLC.
- [F2]Transfer of shares held in dissolved trusts to the Reporting Person.
- [F3]Transfer of shares to Christal M.M. Mickle.
- [F4]Common stock that was previously held jointly by the Reporting Person and Christal M.M. Mickle, and is now held solely by Ms. Mickle.
- [F5]The Reporting Person is the sole manager member of Mickle Investments, LLC.
- [F6]Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). 25% of the shares will vest on August 20, 2022 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.
Documents
Issuer
KEMPHARM, INC
CIK 0001434647
Entity typeother
Related Parties
1- filerCIK 0001638365
Filing Metadata
- Form type
- 4
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 4:51 PM ET
- Size
- 20.2 KB